A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 11 Apr 2018 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
- 11 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 10 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2019.